A previous study by Fukuoka et al. have shown successful use of gefitinib, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor in human and canine cultured corticotropinoma (27). The gene discussed is EGFR; the disease is ACTH-producing pituitary gland adenoma.